Compugen | CGEN - Pre Tax Profit


Compugen reported $-7.66M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Arca Biopharma USD -31.82M 2.24M Mar/2026
aTyr Pharma USD -153K 25.59M Mar/2026
Bio Path USD -976K 3.62M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Cara Therapeutics USD -6.8M 1.9M Mar/2026
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -7.66M 64.51M Mar/2026
Immunic USD -19.3M 6.28M Dec/2025
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
RedHill Biopharma USD -1.54M 12M Jun/2024
TherapeuticsMD USD -1.05M 241K Jun/2024